Richard Rudick
Richard Rudick
E-mailová adresa ověřena na:
Axonal transection in the lesions of multiple sclerosis
BD Trapp, J Peterson, RM Ransohoff, R Rudick, S Mörk, L Bö
New England Journal of Medicine 338 (5), 278-285, 1998
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman, PW O'Connor, E Havrdova, M Hutchinson, L Kappos, ...
New England Journal of Medicine 354 (9), 899-910, 2006
Defining the clinical course of multiple sclerosis: the 2013 revisions
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
LD Jacobs, DL Cookfair, RA Rudick, RM Herndon, JR Richert, ...
Annals of Neurology: Official Journal of the American Neurological …, 1996
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick, WH Stuart, PA Calabresi, C Confavreux, SL Galetta, ...
New England Journal of Medicine 354 (9), 911-923, 2006
Development of a multiple sclerosis functional composite as a clinical trial outcome measure
GR Cutter, ML Baier, RA Rudick, DL Cookfair, JS Fischer, J Petkau, ...
Brain 122 (5), 871-882, 1999
Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis
A Chang, WW Tourtellotte, R Rudick, BD Trapp
New England Journal of Medicine 346 (3), 165-173, 2002
The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment
JS Fischer, RA Rudick, GR Cutter, SC Reingold, ...
Multiple Sclerosis Journal 5 (4), 244-250, 1999
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients
R Dutta, J McDonough, X Yin, J Peterson, A Chang, T Torres, T Gudz, ...
Annals of neurology 59 (3), 478-489, 2006
Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS
RA Rudick, E Fisher, JC Lee, J Simon, L Jacobs, ...
Neurology 53 (8), 1698-1698, 1999
Gray matter atrophy in multiple sclerosis: a longitudinal study
E Fisher, JC Lee, K Nakamura, RA Rudick
Annals of Neurology: Official Journal of the American Neurological …, 2008
Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis
RHB Benedict, J DeLuca, G Phillips, N LaRocca, LD Hudson, R Rudick, ...
Multiple Sclerosis Journal 23 (5), 721-733, 2017
Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients
C Bjartmar, G Kidd, S Mörk, R Rudick, BD Trapp
Annals of neurology 48 (6), 893-901, 2000
Axonal pathology in multiple sclerosis: relationship to neurologic disability
BD Trapp, R Ransohoff, R Rudick
Current opinion in neurology 12 (3), 295-302, 1999
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis
RA Marrie, R Rudick, R Horwitz, G Cutter, T Tyry, D Campagnolo, ...
Neurology 74 (13), 1041-1047, 2010
Benefit of interferon β-1a on MSFC progression in secondary progressive MS
JA Cohen, GR Cutter, JS Fischer, AD Goodman, FR Heidenreich, ...
Neurology 59 (5), 679-687, 2002
Recommendations from the national multiple sclerosis society clinical outcomes assessment task force
R Rudick, J Antel, C Confavreux, G Cutter, G Ellison, J Fischer, F Lublin, ...
Annals of Neurology: Official Journal of the American Neurological …, 1997
Neuropsychological effects of interferon β‐1a in relapsing multiple sclerosis
JS Fischer, RL Priore, LD Jacobs, DL Cookfair, RA Rudick, RM Herndon, ...
Annals of neurology 48 (6), 885-892, 2000
A longitudinal study of brain atrophy in relapsing multiple sclerosis
JH Simon, LD Jacobs, MK Campion, RA Rudick, DL Cookfair, ...
Neurology 53 (1), 139-139, 1999
Eight-year follow-up study of brain atrophy in patients with MS
E Fisher, RA Rudick, JH Simon, G Cutter, M Baier, JC Lee, D Miller, ...
Neurology 59 (9), 1412-1420, 2002
Systém momentálně nemůže danou operaci provést. Zkuste to znovu později.
Články 1–20